Thereby, targeting LAPTM4B may also improve the antitumor effects in HCC by inhibiting autophagy or antagonize HDAC2 dysregulated tumors, which requires subsequent more specific studies to determine. The gene discussed is HDAC2; the disease is hepatocellular carcinoma.